Objectives Preeclampsia remains a major cause of maternal mortality and morbidity
worldwide with increased risk for cardiovascular disease later in life. Many previous studies
have examined several biomarkers including E-selectin. We aimed to assess the role of sE-
selectin together with platelet count and mean platelet volume (MPV) as biomarkers for the
prediction of preeclampsia. Study design and major outcome measures This case-control
study included 85 pregnant women; 40 healthy (mean age 27.1±4.8 years) and 45 with …